Fisher & Paykel Healthcare reported FY’21 (to March 31) revenue growth of 56.0% year over year as the pandemic elevated demand from hospitals and care homes. The firm hasn’t provided guidance for the coming year, increasing the importance of high frequency datasets such as Panjiva’s supply chain data. U.S. seaborne imports linked to the firm climbed 19.8% year over year in calendar Q1’21 before surging 60.2% higher in April. The firm, like many others, has faced logistics disruptions, raising costs though it has “opted not to increase prices” even though it anticipates “freight costs wil...